Encompass Health (NYSE:EHC) declared a quarterly dividend on Friday, May 4th, Zacks reports. Stockholders of record on Monday, July 2nd will be paid a dividend of 0.25 per share on Monday, July 16th. This represents a $1.00 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend is Friday, June 29th.
Shares of Encompass Health opened at $67.08 on Thursday, MarketBeat reports. Encompass Health has a 52-week low of $42.21 and a 52-week high of $69.60. The stock has a market capitalization of $6.73 billion, a PE ratio of 24.30, a PEG ratio of 1.55 and a beta of 0.37. The company has a debt-to-equity ratio of 1.77, a current ratio of 1.24 and a quick ratio of 1.24.
Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, April 26th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.12. Encompass Health had a return on equity of 20.76% and a net margin of 6.76%. The firm had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.03 billion. equities analysts predict that Encompass Health will post 3.39 earnings per share for the current fiscal year.
Several research analysts have recently issued reports on the company. Credit Suisse Group restated an “outperform” rating and issued a $65.00 price objective (up from $61.00) on shares of Encompass Health in a research note on Friday, March 16th. Craig Hallum raised their price objective on Encompass Health from $63.00 to $71.00 and gave the stock a “buy” rating in a research note on Monday, April 30th. Royal Bank of Canada raised their price objective on Encompass Health to $69.00 and gave the stock an “outperform” rating in a research note on Monday, April 30th. ValuEngine upgraded Encompass Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, April 27th. Finally, Robert W. Baird lifted their price target on Encompass Health from $59.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, April 30th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $67.33.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.